The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Paul Rutgeerts

Division of Gastroenterology

University of Leuven Hospitals

Leuven

Belgium

[email]@uz.kuleuven.ac.be

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Gastroenterology, University of Leuven Hospitals, Leuven, Belgium. 1999 - 2010
  • University Hospital Gashuisberg, Department of Internal Medicine Herestraat 49, 3000 Leuven, Belgium. 2001 - 2007
  • University of Leuven, Belgium. 2004

References

  1. Predicting the response to infliximab from trough serum levels. Rutgeerts, P., Vermeire, S., Van Assche, G. Gut (2010) [Pubmed]
  2. Biological therapies for inflammatory bowel diseases. Rutgeerts, P., Vermeire, S., Van Assche, G. Gastroenterology (2009) [Pubmed]
  3. Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFalpha, improves health-related quality of life in patients with moderate to severe Crohn's disease. Rutgeerts, P., Schreiber, S., Feagan, B., Keininger, D.L., O'Neil, L., Fedorak, R.N. Int. J. Colorectal. Dis (2008) [Pubmed]
  4. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?. Rutgeerts, P., Vermeire, S., Van Assche, G. Gut (2007) [Pubmed]
  5. Review article: Infliximab therapy for inflammatory bowel disease--seven years on. Rutgeerts, P., Van Assche, G., Vermeire, S. Aliment. Pharmacol. Ther. (2006) [Pubmed]
  6. Onercept for moderate-to-severe Crohn's disease: a randomized, double-blind, placebo-controlled trial. Rutgeerts, P., Sandborn, W.J., Fedorak, R.N., Rachmilewitz, D., Tarabar, D., Gibson, P., Haagen Nielsen, O., Wild, G., Schreiber, S., Pena Rossi, C., Zignani, M. Clin. Gastroenterol. Hepatol. (2006) [Pubmed]
  7. Review article: recurrence of Crohn's disease after surgery - the need for treatment of new lesions. Rutgeerts, P. Aliment. Pharmacol. Ther. (2006) [Pubmed]
  8. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Rutgeerts, P., Van Assche, G., Vermeire, S., D'Haens, G., Baert, F., Noman, M., Aerden, I., De Hertogh, G., Geboes, K., Hiele, M., D'Hoore, A., Penninckx, F. Gastroenterology (2005) [Pubmed]
  9. Infliximab for induction and maintenance therapy for ulcerative colitis. Rutgeerts, P., Sandborn, W.J., Feagan, B.G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S.B., Lichtenstein, G.R., de Villiers, W.J., Present, D., Sands, B.E., Colombel, J.F. N. Engl. J. Med. (2005) [Pubmed]
  10. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Rutgeerts, P., Feagan, B.G., Lichtenstein, G.R., Mayer, L.F., Schreiber, S., Colombel, J.F., Rachmilewitz, D., Wolf, D.C., Olson, A., Bao, W., Hanauer, S.B. Gastroenterology (2004) [Pubmed]
  11. Optimizing anti-TNF treatment in inflammatory bowel disease. Rutgeerts, P., Van Assche, G., Vermeire, S. Gastroenterology (2004) [Pubmed]
  12. Review article: treatment of perianal fistulizing Crohn's disease. Rutgeerts, P. Aliment. Pharmacol. Ther. (2004) [Pubmed]
  13. Modern therapy for inflammatory bowel disease. Rutgeerts, P. Scand. J. Gastroenterol. Suppl. (2003) [Pubmed]
  14. Protagonist: Crohn's disease recurrence can be prevented after ileal resection. Rutgeerts, P. Gut (2002) [Pubmed]
  15. Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease. Rutgeerts, P. Gut (2001) [Pubmed]
  16. Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications. Baert, F.J., Rutgeerts, P.R. Int. J. Colorectal. Dis (1999) [Pubmed]
 
WikiGenes - Universities